Cargando…

Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021

BACKGROUND: There is a long history in Japan of public concerns about vaccine adverse events. Few studies have assessed how mobile messenger apps affect COVID-19 vaccine hesitancy. METHODS: Corowa-kun, a free chatbot, was created on February 6, 2021 in LINE, the most popular messenger app in Japan....

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Takaaki, Nishina, Yuka, Tomoi, Hana, Harada, Ko, Tanaka, Kyuto, Matsumoto, Eiyu, Horimukai, Kenta, Ishihara, Jun, Sasaki, Shugo, Inaba, Kanako, Seguchi, Kyosuke, Takahashi, Hiromizu, Salinas, Jorge L., Yamada, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174339/
https://www.ncbi.nlm.nih.gov/pubmed/35750541
http://dx.doi.org/10.1016/j.vaccine.2022.06.007
Descripción
Sumario:BACKGROUND: There is a long history in Japan of public concerns about vaccine adverse events. Few studies have assessed how mobile messenger apps affect COVID-19 vaccine hesitancy. METHODS: Corowa-kun, a free chatbot, was created on February 6, 2021 in LINE, the most popular messenger app in Japan. Corowa-kun provides instant, automated answers to 70 frequently asked COVID-19 vaccine questions. A cross-sectional survey with 21 questions was performed within Corowa-kun during April 5–12, 2021. RESULTS: A total of 59,676 persons used Corowa-kun during February–April 2021. Of them, 10,192 users (17%) participated in the survey. Median age was 55 years (range 16–97), and most were female (74%). COVID-19 vaccine hesitancy reported by survey respondents decreased from 41% to 20% after using Corowa-kun. Of the 20% who remained hesitant, 16% (1,675) were unsure, and 4% (3 6 4) did not intend to be vaccinated. Factors associated with vaccine hesitancy were: age 16–34 (odds ratio [OR] = 3.7; 95% confidential interval [CI]: 3.0–4.6, compared to age ≥ 65), female sex (OR = 2.4; Cl: 2.1–2.8), and history of a previous vaccine side-effect (OR = 2.5; Cl: 2.2–2.9). Being a physician (OR = 0.2; Cl: 0.1–0.4) and having received a flu vaccine the prior season (OR = 0.4; Cl: 0.3–0.4) were protective. CONCLUSIONS: A substantial number of people used the chabot in a short period. Mobile messenger apps could be leveraged to provide accurate vaccine information and to investigate vaccine intention and risk factors for vaccine hesitancy.